Results-The D and I allele frequencies were respectively 0-63 and 0 37 in the overall healthy blood donor group and 0-66 and 0*34 in the overall study group.
with proven coronary atherosclerosis (n = 255) or with angiographically normal coronary arteries (n = 133). A further group of 290 healthy blood donors was tested for allele frequency comparison. Interventions-ACEIID polymorphism was analysed with polymerase chain reaction on DNA from white blood cells. Main outcome measures-Coronary atherosclerosis, myocardial infarction, hypertension. Results-The D and I allele frequencies were respectively 0-63 and 0 37 in the overall healthy blood donor group and 0-66 and 0*34 in the overall study group.
In the latter, univariate analysis showed (1) that coronary atherosclerosis (255 patients) was associated with the deletion allele, with an odds ratio (OR) of 5*78 for DDIII, P < 0*001, and 2*39 for IDIII, P = 0-006; and (2) that myocardial infarction (154 patients) was associated with the DD genotype (OR DDIII = 2-56, P = 0.007), but not with the ID genotype (OR DDIII = 196, P = 0.056). Finally, hypertension proved to be unrelated with the ACE genotype. The distribution between the three genotypes of known risk factors for coronary artery disease was similar.
Logistic regression modelling, performed to test the association of the selected risk factors simultaneously with coronary atherosclerosis and myocardial infarction, showed that the deletion allele (whether DD or ID) was the strongest risk factor for atherosclerosis, and that the D allele was significantly associated with the risk of infarction (although to a lesser extent than with coronary atherosclerosis). Conclusion-ACE deletion polymorphism is strongly and independently associated with coronary atherosclerosis and, to a lesser extent, with myocardial infarction. As such, the results are analogous to what has already been reported in French white, Japanese, and Welsh coronary patients.
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The deletion (D) or the insertion (1) of a 250 base pair (bp) DNA fragment in the angiotensin I converting enzyme (ACE) gene accounts for the three main ACE genotypes, II, ID, and DD.1 About 50% of total phenotypic variance in serum ACE corresponds to this insertion/deletion polymorphism: the concentration of serum ACE is lowest in homozygotes with the longer allele (II) and highest in homozygotes with the shorter allele (DD); ID heterozygotes show intermediate levels.
2A
Deletion polymorphism has been found to be a potent risk factor for myocardial infarction, both in white French patients otherwise defined as low risk on account of the absence of cardiovascular risk factors,5 and in a recently reported US population. 6 The same polymorphism has been associated with a family history of fatal myocardial infarction in a part of the ECTIM population.7 More recently, it has been reported that ACE gene deletion is strongly associated with coronary artery disease in French white patients with noninsulin-dependent diabetes mellitus,8 in Japanese coronary patients,9 and in a Welsh community.'0 Furthermore, the same polymorphism proved to be associated with the so called "ischaemic cardiomyopathy"," in which severe and diffuse coronary atherosclerosis and myocardial infarction coexist. 12 (1) Coronary artery status, as documented in 286 patients by coronary angiography in the current (n = 163) or in previous (n = 115) admissions to our own or other hospitals, or by pathology on necropsy (n = 6) or explanted heart (n = 2) studies. We used standard angiography diagnostic criteria to define the occurrence of coronary artery disease.'5 16 The occurrence of both critical and subcritical luminal narrowings was considered as the expression of coronary atherosclerosis, and was the criterion for the inclusion of the case in the coronary artery disease group.
(2) Acute (n = 20) or previous myocardial infarction (n = 82), either single (n = 71) or multiple (n = 31, 11 of whom had ischaemic cardiomyopathy). In this group there were no patients with endocarditis, prosthetic valves, oral contraceptive use, viral illnesses, or other conditions which are known, albeit rarely, to cause myocardial infarction with non-atherosclerotic coronary arteries.17-2'
The interval between coronary angiographies performed on other than the present hospital admission varied from months to years. Angiographically positive cases were included irrespective of this interval, since they were undoubtedly positive (this group included, for example, patients who had undergone previous surgical revascularisation or coronary angioplasty, or patients with valvar heart disease and associated coronary artery disease). For negative cases (patients with angiographically normal coronary arteries), we only included those patients who underwent coronary angiography on the current hospital admission or who had recently (< one year) undergone angiography and had been followed up in our cardiology department. This group consisted of idiopathic dilated cardiomyopathies, valvar heart diseases without coronary atherosclerosis, atypical chest pain with normal coronary arteries (X syndrome), and a minor series of rarer disorders, such as cardiac myxoma, amyloidosis, and so on.
We further tested 290 randomly selected blood donors (210 were males) aged 35 CI, confidence interval. 
RISK FACTORS AND ACE GENOTYPE
Given the association of ACE ID polymorphism with coronary atherosclerosis, we evaluated the distribution in the three genotypes of a series of potentially disease related variables, namely, age, sex, family history of ischaemic heart disease, hypertension, diabetes, hypercholesterolaemia, obesity, and smoking. As shown in table 4, a similar distribution was observed in the three genotypes for all the categorical covariates.
LOGISTIC MODELS
We performed logistic regression to test the association of the selected risk factors with atherosclerosis and myocardial infarction.
Coronary atherosclerosis
In our final logistic model, age, sex, ACE genotypes DD and ID, hypertension, hypercholesterolaemia, and smoking appeared to be independent predictors of coronary atherosclerosis. Table 5 gives the regression coefficients together with their significance and their logistic ORs (with 95% confidence intervals). The presence of the shorter allele (D) represents the most important risk factor for coronary atherosclerosis. The occurrence of a DD genotype multiplies the risk by 7 in comparison with II pattern, whereas the ID genotype multiplies the risk by 3. As shown in table 5, the strongest association for coronary atherosclerosis was with DD and ID ACE genotypes, sex, and smoking.
Myocardial infarction
In our logistic model, sex, ACE genotypes DD and ID, and high cholesterol concentrations appeared to be independent predictors of myocardial infarction. Table 6 gives the logistic regression coefficients, along with their significance and their logistic ORs (with 95% confidence intervals). The DD genotype represented a lower risk factor for myocardial infarction than for atherosclerosis: it actually multiplied the risk by 3-5 in comparison with the II pattern. Moreover, the ID genotype, which had a borderline significant association with infarction in traditional 2 x 2 analysis (P = 0056), proved in the final logistic model (after controlling for the other covariates) to multiply the risk by 2-7 in comparison with the II pattern. In addition, sex (male) and high cholesterol levels both appeared to increase the risk of myocardial infarction. None of the other variables tested in the model was found to predict myocardial infarction. showed that plasma P thromboglobulin, which is a marker of in vivo platelet activation, is significantly reduced by treatment in patients with hypertension.38 In the SAVE and in the SOLVD trials, the long term administration of an ACE inhibitor was associated with reductions in recurrent myocardial infarction and in mortality.39 40 However, the precise mechanism by which ACE might influence acute coronary occlusion is still a matter of hypothesis.
So far as ACE genotype and hypertension is concerned, the present study joins Cambien and co-workers,5 Jeunemaitre A possible limit of the present study derives from the use (as control for the group with coronary atherosclerosis) of patients with cardiac diseases in which coronary angiography showed a normal coronary tree, rather than of healthy patients with normal coronary arteries. This limit is obviously intrinsic to this type of study, given the impossibility of our knowing the status of coronary arteries in healthy subjects. To prevent population related bias and to be sure that the genotype frequencies in our test group were comparable with those that of the general population, we studied 290 healthy blood donors: the similarity of I and D allele frequencies between the two groups indicates that allele frequency distribution is analogous in the overall test group and that only the occurrence of coronary atherosclerosis allows us to recognise differences in I and D allele distribution. It is likely that our control group of clinically healthy subjects (their mean age was lower than that of the study group) included cases with silent coronary artery disease, as well as cases who will in future develop ischaemic disease and myocardial infarction. It should also be noted that not only coronary atherosclerosis43 but also myocardial scars, documenting previous infarctions, may be occasional findings in necropsy studies.44 CONCLUSION Our study identifies ACE gene deletion as strongly and independently associated with coronary atherosclerosis. The opposite condition in patients with angiographically normal coronary arteries gives strength to previous data in French, Japanese, and Welsh coronary patient series, in which the coronary arteries of control group subjects were supposed to be normal on the basis of clinical data.7 Furthermore, our results confirm in white Italian patients what Cambien et al5 and Ludwig et al6 found in European and US populations, namely an association between the D allele and myocardial infarction which, in our series, was less than the association between the D allele and coronary atherosclerosis, but was nonetheless significant.
